2011
DOI: 10.47102/annals-acadmedsg.v40n5p213
|View full text |Cite
|
Sign up to set email alerts
|

Biomimetic Nanostructured Materials — Potential Regulators for Osteogenesis?

Abstract: Nanostructured materials are gaining new impetus owing to the advancements in material fabrication techniques and their unique properties (their nanosize, high surface area-to-volume ratio, and high porosity). Such nanostructured materials mimic the subtleties of extracellular matrix (ECM) proteins, creating artificial microenvironments which resemble the native niches in the body. On the other hand, the isolation of mesenchymal stem cells (MSCs) from various tissue sources has resulted in the interest to stud… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 24 publications
(1 citation statement)
references
References 70 publications
0
1
0
Order By: Relevance
“…Various approaches have been proposed to increase the biological osteostimulating effect of bone implants, such as chemical modification of CP (substitution by cations, change of synthesis conditions etc. ), and combination of scaffolds with bioactive molecules, such as growth factors, cytokines, peptides or small molecules targeting bone precursor cells, bone formation and metabolism or use cell-based strategies with progenitor cells combined or not with active molecules [ 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 ]. However, most of the proposed methods are excessively labor-intensive or expensive to produce, which reduces the availability of such materials to their main consumer, the average patient.…”
Section: Discussionmentioning
confidence: 99%
“…Various approaches have been proposed to increase the biological osteostimulating effect of bone implants, such as chemical modification of CP (substitution by cations, change of synthesis conditions etc. ), and combination of scaffolds with bioactive molecules, such as growth factors, cytokines, peptides or small molecules targeting bone precursor cells, bone formation and metabolism or use cell-based strategies with progenitor cells combined or not with active molecules [ 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 ]. However, most of the proposed methods are excessively labor-intensive or expensive to produce, which reduces the availability of such materials to their main consumer, the average patient.…”
Section: Discussionmentioning
confidence: 99%